Skip to main content
OpenTrials

Clinical trial condition

Geographic Atrophy

Explore clinical trials studying Geographic Atrophy. Study availability and eligibility vary by location and protocol.

86 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Geographic Atrophy trial results

Completed

GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

NCT03815825

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • IONIS Investigative Site Phoenix, Arizona, United States
  • IONIS Investigative Site Phoenix, Arizona, United States
  • IONIS Investigative Site Phoenix, Arizona, United States
  • IONIS Investigative Site Sun City, Arizona, United States
View all 88 locations
View Trial Details
Completed

A Study to Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

NCT06006585

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Bay Area Retina Associates - Walnut Creek Walnut Creek, California, United States
  • Florida Retina Institute Jacksonville, Florida, United States
  • Florida Eye Associates Melbourne, Florida, United States
  • Verum Research, LLC Eugene, Oregon, United States
View Trial Details
Completed

ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration

NCT04744662

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Chatswood Retina Chatswood, New South Wales, Australia
  • Retina and Eye Consultants Hurtsville Hurstville, New South Wales, Australia
  • Retinology Institute Glen Iris, Victoria, Australia
  • Queensland Eye Institute Melbourne, Victoria, Australia
View Trial Details
Completed

A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy

NCT04656561

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Site 5 Phoenix, Arizona, United States
  • Site 31 Bakersfield, California, United States
  • Site 2 Beverly Hills, California, United States
  • Site 19 Mountain View, California, United States
View all 53 locations
View Trial Details
Completed

Geographic Atrophy Long-Terms Outcomes Study

NCT06499571

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Sydney West Retina Westmead, New South Wales, Australia
  • Centre Hospitalier de la Croix Rousse Lyon, Rhone, France
  • Universitaetsklinikum Muenster Münster, North Rhine-Westphalia, Germany
  • Azienda Socio Sanitaria Territoriale Fatebenefratelli (Presidio Ospedale Sacco) Milan, Italy
View Trial Details
Completed

A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

NCT03525613

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Arizona Retina & Vitreous Consultants Phoenix, Arizona, United States
  • California Retina Consultants Bakersfield, California, United States
  • Retina Vitreous Associates Medical Group Beverly Hills, California, United States
  • Retinal Diagnostic Center Campbell, California, United States
View all 112 locations
View Trial Details
Completed

Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

NCT03525600

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Retinal Research Institute Phoenix, Arizona, United States
  • Associated Retina Consultants, Ltd Phoenix, Arizona, United States
  • Retina Institute of California dba Acuity Eye Grp Arcadia, California, United States
  • California Retina Consultants Bakersfield, California, United States
View all 141 locations
View Trial Details
Completed

Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD

NCT02684578

Conditions
Age-Related Macular Degeneration, Dry Macular Degeneration, Eye Diseases, +5 more
Locations
  • University of California, Davis Davis, California, United States
  • Palo Alto Veteran Affairs Medical Center Palo Alto, California, United States
  • Retinal Consultants Medical Group Sacramento, California, United States
  • San Francisco Veteran Affairs Medical Center San Francisco, California, United States
View Trial Details

Related conditions